| 000 | 01901 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516084122.0 | ||
| 264 | 0 | _c20120625 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/bjc.2012.85 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGallardo, A | |
| 245 | 0 | 0 |
_aIncreased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cApr 2012 |
||
| 300 |
_a1367-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xpharmacology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aErbB Receptors _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPTEN Phosphohydrolase _xmetabolism |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xgenetics |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xgenetics |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTrastuzumab |
| 700 | 1 | _aLerma, E | |
| 700 | 1 | _aEscuin, D | |
| 700 | 1 | _aTibau, A | |
| 700 | 1 | _aMuñoz, J | |
| 700 | 1 | _aOjeda, B | |
| 700 | 1 | _aBarnadas, A | |
| 700 | 1 | _aAdrover, E | |
| 700 | 1 | _aSánchez-Tejada, L | |
| 700 | 1 | _aGiner, D | |
| 700 | 1 | _aOrtiz-Martínez, F | |
| 700 | 1 | _aPeiró, G | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 106 _gno. 8 _gp. 1367-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.2012.85 _zAvailable from publisher's website |
| 999 |
_c21657338 _d21657338 |
||